News & Events zu Accuray Incorporated (ARAY)ARAYAccuray Incorporated

Accuray Shareholders Approve TCW Transactions

Accuray Incorporated announced that stockholders approved all proposals presented at the company's Special Meeting of Stockholders held on October 6, enabling Accuray to complete its previously announced transactions with TCW Asset Management Company, the company's primary lender and largest shareholder. The approved proposals will enable Accuray to complete the previously announced TCW financing transaction. The approved proposals included the issuance of shares of common stock in accordance with Nasdaq Listing Rule 5635 in connection with the company's previously announced financing transaction, an increase in the number of authorized shares of common stock, and a reverse stock split of the company's common stock, at a ratio ranging from any whole number between 1-for-15 and 1-for-40 determined by Accuray's board of directors in its discretion. The board of directors maintains the discretion to select any whole number ratio within the approved range and the exact timing of the reverse stock split. The board of directors is evaluating market conditions and other relevant factors in determining the appropriate ratio and timing for the reverse split.

Accuray Partners with Samsung to Enhance CyberKnife Imaging Technology

Accuray Incorporated (ARAY) announced that it had entered into agreements with Samsung HME America (SSNLF) to pursue advanced volumetric imaging capabilities for the CyberKnife System. The announcement coincides with the American Society of Radiation Oncology, ASTRO, Annual Meeting in Boston, Massachusetts, where the companies are highlighting their collaboration. The collaboration represents another example of Accuray's strategy to address customer priorities through targeted partnerships that bring together complementary expertise.